Esther E. Freeman

Last updated

Esther Ellen Freeman
Born1979 (age 45–46)
Alma mater
Scientific career
Institutions
Thesis The role of herpes simplex virus Type 2 in the spread and control of HIV in four Sub-Saharan African Cities  (2006)

Esther Ellen Freeman (born 1979) is an American physician who is an Associate Professor of Dermatology at the Harvard Medical School and Director of Global Health Dermatology at Massachusetts General Hospital. Her research considers HIV infection with AIDS-defining malignancies, including Kaposi's sarcoma. During the COVID-19 pandemic Freeman established the American Academy of Dermatology register of COVID-19 skin complaints, through which she identified novel symptoms of COVID-19 in the skin.

Contents

Early life and education

Freeman attended Milton Academy. [1] As a child she was a competitive skier, and competed in the national championships at the age of twelve. [1] [2] By the age of fifteen Freeman was a member of the United States freestyle skiing team. [1] Freeman earned her undergraduate degree at Dartmouth College. [1] Throughout her college career she skied in World Cup competitions and was a member of the Dartmouth sailing team. [1] During her studies at Dartmouth, Freeman spent time in Kenya and Mexico. In 2002 she was selected as a Marshall Scholar, and moved to the United Kingdom to complete her graduate studies. [1] She was a graduate student at the London School of Hygiene & Tropical Medicine, where she studied HIV epidemiology. [3] After completing her doctorate Freeman returned to the United States, where she started a medical degree at Harvard Medical School, and soon after completed her specialist training in dermatology, at the Harvard Combined Dermatology Residency Training program.[ citation needed ]

Research and career

In 2011 Freeman began work with the World Health Organization, drafting guidelines on how to treat skin conditions that were associated with HIV in the developing world. [4] For these efforts she was awarded the 2012 American Academy of Dermatology Members Making a Difference Award. [5]

In 2013 Freeman was appointed Director of Global Health Dermatology at the Massachusetts General Hospital. Here she continued to investigate HIV dermatology, with a particular focus on Kaposi's sarcoma. [6] She serves on the leadership team of the International Alliance of Global Health Dermatology(GLODERM). [7]

Leadership during the COVID-19 pandemic and other outbreaks

Freeman was a member of the American Academy of Dermatology task force on coronavirus disease. [8] As part of this effort, she launched and helped to compile a registry of skin complaints of COVID-19 patients, identifying several new symptoms of COVID-19 that present in the skin. [9] [10] [11] Freeman has since been involved in leadership for several other outbreaks, including the global Mpox outbreak in 2022, where she served on the WHO Clinical Guidelines Committee for Mpox and also compiled an international registry to more deeply characterize skin manifestations of the virus. Her work on outbreaks has been features in the Washington Post and NPR, among others. [12] [13] [14] [15] [16] [17] [18]

Selected publications

References

  1. 1 2 3 4 5 6 "Esther Freeman named 2002 Marshall Scholarship Winner". Milton Academy. December 6, 2001. Retrieved January 5, 2020.
  2. ↑ "FREEMAN Esther - Athlete Information". www.fis-ski.com. Retrieved May 1, 2020.
  3. ↑ Freeman, Esther; University of London (2006). The role of herpes simplex virus Type 2 in the spread and control of HIV in four Sub-Saharan African Cities. London: University of London. OCLC   500303273.
  4. ↑ "Global Health Dermatology". Massachusetts General Hospital. Retrieved May 1, 2020.
  5. ↑ "Members Making a Difference Award". www.aad.org. Retrieved May 1, 2020.
  6. ↑ "2013 Award and Grant Recipients". American Skin Association. Retrieved May 1, 2020.
  7. ↑ "Introducing the International Alliance for Global Health Dermatology (GLODERM)". ILDS. March 29, 2019. Archived from the original on May 15, 2019. Retrieved May 1, 2020.
  8. ↑ Rodriguez, Adrianna. "Doctors find more cases of 'COVID toes' in dermatological registry. Here's what they learned". USA TODAY. Retrieved May 1, 2020.
  9. ↑ "COVID-19 dermatology registry". www.aad.org. Retrieved May 1, 2020.
  10. ↑ "'Frostbite' toes and other peculiar rashes may be signs of hidden coronavirus infection, especially in the young". The Seattle Times. April 29, 2020. Retrieved May 1, 2020.
  11. ↑ "AAD Registry for Skin Manifestations of COVID-19: Q&A With Dr Freeman". The Dermatologist. Retrieved May 1, 2020.
  12. ↑ Blumenthal, Kimberly G.; Freeman, Esther E.; Saff, Rebecca R.; Robinson, Lacey B.; Wolfson, Anna R.; Foreman, Ruth K.; Hashimoto, Dean; Banerji, Aleena; Li, Lily; Anvari, Sara; Shenoy, Erica S. (April 2021). "Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2". New England Journal of Medicine. 384 (13): 1273–1277. doi:10.1056/NEJMc2102131. ISSN   0028-4793. PMC   7944952 . PMID   33657292.
  13. ↑ McMahon, Devon E.; Amerson, Erin; Rosenbach, Misha; Lipoff, Jules B.; Moustafa, Danna; Tyagi, Anisha; Desai, Seemal R.; French, Lars E.; Lim, Henry W.; Thiers, Bruce H. (2021). "Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases". Journal of the American Academy of Dermatology. 85 (1): 46–55. doi:10.1016/j.jaad.2021.03.092. PMC   8024548 . PMID   33838206.
  14. ↑ "The spectrum of COVID-19–associated dermatologic manifestations: An international registry of 716 patients from 31 countries". scholar.google.com. Retrieved December 30, 2024.
  15. ↑ Seth, Divya; Cheldize, Khatiya; Brown, Danielle; Freeman, Esther E. (September 2017). "Global Burden of Skin Disease: Inequities and Innovations". Current Dermatology Reports. 6 (3): 204–210. doi:10.1007/s13671-017-0192-7. ISSN   2162-4933. PMC   5718374 . PMID   29226027.
  16. ↑ "Global resource shortages during COVID-19: Bad news for low-income countries". scholar.google.com. Retrieved December 30, 2024.
  17. ↑ "The American Academy of Dermatology COVID-19 registry: crowdsourcing dermatology in the age of COVID-19". scholar.google.com. Retrieved December 30, 2024.
  18. ↑ "Developing a platform for global health dermatology mentorship and collaboration: Introducing the International Alliance for Global Health Dermatology". scholar.google.com. Retrieved December 30, 2024.
  19. ↑ Freeman, Esther E; Weiss, Helen A; Glynn, Judith R; Cross, Pamela L; Whitworth, James A; Hayes, Richard J (2006). "Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies". AIDS. 20 (1): 73–83. doi: 10.1097/01.aids.0000198081.09337.a7 . ISSN   0269-9370. PMID   16327322. S2CID   37946948.
  20. ↑ Freeman, Esther E.; Orroth, Kate K.; White, Richard G.; Glynn, Judith R.; Bakker, Roel; Boily, Marie-Claude; Habbema, Dik; Buvé, Anne; Hayes, Richard (August 1, 2007). "Proportion of new HIV infections attributable to herpes simplex 2 increases over time: simulations of the changing role of sexually transmitted infections in sub-Saharan African HIV epidemics". Sexually Transmitted Infections. 83 (suppl 1): i17 –i24. doi: 10.1136/sti.2006.023549 . ISSN   1368-4973. PMID   17405782.
  21. ↑ White, Richard G.; Glynn, Judith R.; Orroth, Kate K.; Freeman, Esther E.; Bakker, Roel; Weiss, Helen A.; Kumaranayake, Lilani; Habbema, J Dik F.; Buvé, Anne; Hayes, Richard J. (2008). "Male circumcision for HIV prevention in sub-Saharan Africa: Who, what and when?". AIDS. 22 (14): 1841–1850. doi:10.1097/QAD.0b013e32830e0137. PMID   18753931.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.